[go: up one dir, main page]

EP1062359A1 - Enzymatic preparation of glucose syrup from starch - Google Patents

Enzymatic preparation of glucose syrup from starch

Info

Publication number
EP1062359A1
EP1062359A1 EP99906094A EP99906094A EP1062359A1 EP 1062359 A1 EP1062359 A1 EP 1062359A1 EP 99906094 A EP99906094 A EP 99906094A EP 99906094 A EP99906094 A EP 99906094A EP 1062359 A1 EP1062359 A1 EP 1062359A1
Authority
EP
European Patent Office
Prior art keywords
amylase
termamyl
glucose syrup
seq
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99906094A
Other languages
German (de)
French (fr)
Inventor
Barrie Edmund Novo Nordisk A/S NORMAN
Hanne Vang Novo Nordisk A/S HENDRIKSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of EP1062359A1 publication Critical patent/EP1062359A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C13—SUGAR INDUSTRY
    • C13K—SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES
    • C13K1/00—Glucose; Glucose-containing syrups
    • C13K1/06—Glucose; Glucose-containing syrups obtained by saccharification of starch or raw materials containing starch

Definitions

  • the present invention relates to a process for the preparation of starch-hydrolysate syrups having characteristics which render them particularly attractive for a variety of industrial applications, notably in the food industry.
  • the invention makes it possible using one enzyme, for the first time, to obtain syrups of the above-mentioned kind which closely match syrups whose preparation previously only feasible using acid hydrolysis ( i . e . , non-enzymatic hydrolysis) of starch.
  • Glucose syrups with a DE (Dextrose Equivalent) around 42 is widely used in industry as an ingredient in products such as hard boiled candy, toffees, fudge, fondant and the like.
  • the present invention is based on the finding that a glucose syrup with a DE in the range from 35 to 45 having a sugar spectrum close to that of the traditionally acid converted 42 DE glucose syrup can be obtained by treating starch with a 54 substituted variant of Termamyl ® (which is a commercially available Bacillus lichenifor is ⁇ -amylase) .
  • the invention relates to a process for the preparation of a glucose syrup wherein starch is treated with a Termamyl-like ⁇ -amylase comprising a substitution in
  • the invention also relates to a glucose syrup obtainable by the process of the invention. Further, an aspect the invention also relates to the use of said glucose syrup obtainable by the process of the invention as ingredient in food products such as hard boiled candy, toffees, fudge, fondant and the like.
  • Another object of the invention is to provide for the use of a Termamyl-like ⁇ -amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone (i.e., parent enzyme) or a corresponding position in another Termamyl-like ⁇ -amylase for preparing glucose syrup.
  • Figure 1 shown the sugar spectrum of a 42 DE acid converted glucose syrup .
  • Figure 2 shows the sugar spectrum of a Termamyl ® ⁇ i . e . , Bacillus licheniformis ⁇ -amylase from Novo Nordisk shown in SEQ ID NO: 2) converted glucose syrup.
  • Figure 3 shows the sugar spectrum of a V54 substituted Bacillus licheniformis ⁇ -amylase variant converted glucose syrup of the invention.
  • Figure 4 is an alignment of the amino acid sequences of six parent Termamyl-like ⁇ -amylases.
  • the numbers on the Extreme left designate the respective amino acid sequences as follows: 1: Bacillus sp . ⁇ -amylase, 2: Kaoamyl ⁇ -amylase), 3: Bacillus sp . ⁇ -amylase,
  • B amyloliquefaciens ⁇ -amylase (BAN) (SEQ ID NO: 3), 5: Bacillus licheniformis ⁇ -amylase (SEQ ID NO: 2), 6: ⁇ -amylase disclosed in Tsukamoto et al . , Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31.
  • BAN amyloliquefaciens ⁇ -amylase
  • 5 Bacillus licheniformis ⁇ -amylase (SEQ ID NO: 2)
  • 6 ⁇ -amylase disclosed in Tsukamoto et al . , Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31.
  • the present invention is based on the finding that a novel glucose syrup with a DE in the range from 35 to 45 having a sugar spectrum and properties close to that of the traditionally acid converted glucose syrup, often referred to as "42 DE glucose syrup” is obtained by treating starch with a Val54Trp (V54 ) substituted variants of the commercially available Bacillus licheniformis ⁇ -amylase, sold under the trade name Termamyl ® (Novo Nordisk) .
  • V54 Val54Trp
  • Termamyl ® Novo Nordisk
  • Val54 substituted variant can be used to preparing a syrup ⁇ - from starch having a sugar spectrum which is close to that of an acid converted 42 DE glucose syrup as a glucose syrup prepared from starch treated with parent B . li cheniformis ⁇ - amylase (SEQ ID NO: 2) has a sugar spectrum quite different therefrom.
  • the invention relates to a glucose syrup (or speciality syrup) prepared by treating starch with the Bacillus licheniformis ⁇ -amylase shown in SEQ ID NO: 2 comprising a substitution in position Val54 or a Termamyl-like ⁇ -amylase (as defined below) substituted in a position corresponding to Val54 of SEQ ID NO: 2.
  • the glucose syrup of the invention has properties close to that of the traditional acid converted 42 DE syrups with regard to its sugar spectrum, i . e . , composition of dextrose (DPI), maltose (DP2) , maltotriose (DP3) , maltotetraose (DP4) , maltopentaose (DP5) and a number of higher sugars such as DP10 etc.
  • DPI dextrose
  • DP2 maltose
  • DP3 maltotriose
  • DP4 maltopentaose
  • DP5 maltopentaose
  • the rheological properties such as the viscosity, resembles the traditional acid converted DE 42 syrup much closer than a corresponding syrup prepared under the same conditions by treatment with parent B . licheniformis ⁇ -amylase ⁇ i . e . , SEQ ID NO: 2) .
  • Val54 substituted Bacillus licheniformis ⁇ - amylase variant for preparing a glucose syrup of the invention it can be seen that especially the DPI and DP4 sugar content has been increased to a level closer to that of the traditional 42 DE acid converted glucose syrup and the DP5 sugar content has been decreased to a level closer to that of the 42 DE glucose syrup in comparison to the corresponding glucose syrup prepared using parent B. licheniformis ⁇ -amylase. Further, the content of the higher sugars, as can be seen by comparing the peak(s) on the left side of Figures 1 to 3 , are also increased to a level closer to that of the acid converted 42 DE glucose syrup in comparison to corresponding parent B . licheniformis ⁇ -amylase converted starch glucose syrup.
  • the glucose syrup of the invention may be prepared by treating starch with a Val54 substituted Termamyl-like ⁇ - amylase variant for between 20 and 100 hours, preferably 50-80 hours, especially 60-75 hours at temperature in the range around 80-105°C.
  • the pH should be in the range from pH 4-7, preferably from pH 4.5-6.5, especially around pH 5.5-6.2.
  • Termamyl-like ⁇ -amylases which generally seen have a high degree of Calcium dependency, from 20-60 ppm Ca 2+ , preferably around 40 ppm Ca 2+ should be present in the reaction slurry.
  • Enzymatic conversion of starch into a glucose syrup of the acid converted 42 DE syrup type should have a number of advantages including:
  • the Termamyl-like a-amylase may be any ⁇ -amylases produced by Bacillus spp. with a high degree of homology on the amino acid level to SEQ ID NO. 2 herein, as will be defined below.
  • Bacillus spp. with a high degree of homology on the amino acid level to SEQ ID NO. 2 herein, as will be defined below.
  • a not exhaustive list of such enzymes are the following Bacillus sp. ⁇ -amylases :
  • homologous a-amylases include an a-amylase derived from a strain of the Bacillus sp .
  • NCIB 12289, NCIB 12512, NCIB 12513 or DSM 9375 all of which are described in detail in WO 95/26397, and the a-amylase described by Tsukamoto et al . , Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31.
  • Bacillus s . ⁇ -amylases contemplated according to the present invention to be within the definition of Termamyl-like ⁇ -amylases are the ⁇ -amylases disclosed in SEQ ID NO. 1, 2, 3 and 7 of WO 96/23873 and variants thereof, including specifically the ones described in WO 96/23873.
  • the parent Termamyl-like ⁇ -amylase is a hybrid ⁇ -amylase of SEQ ID NO: 2 and SEQ ID NO: 4.
  • the parent hybrid Termamyl-like ⁇ -amylase may be identical to the Termamyl sequence, i.e., the Bacillus licheni formis ⁇ -amylase shown in SEQ ID NO : 2, except that the N- terminal 35 amino acid residues (of the mature protein) has_ been replaced by the N-terminal 33 residues of BAN (mature protein) , i.e., the Bacillus amyloliquefaciens alpha-amylase shown in SEQ ID NO: 4 (the DNA sequence of the Bacillus amyloliquefa ciens alpha-amylase is displayed in SEQ ID NO: 3), which further may have the following mutations: H156Y+A181T+N190F+A209V+Q264S (using the numbering in SEQ ID NO:
  • Termamyl-like ⁇ -amylases include the ⁇ - amylase produced by the B . licheniformis strain described in EP 0,252,666 (ATCC 27811), and the ⁇ -amylases identified in WO
  • Termamyl-like ⁇ -amylases are OptithermTM and TakathermTM (available from Sol- vay) , MaxamylTM (available from Gist-Brocades/Genencor) , Spezyme AATM and Spezyme Delta AATM (available from Genencor) , and Keis- taseTM (available from Daiwa) .
  • Termamyl-like a-amylase is also intended to indicate an a-amylase which, at
  • a "Termamyl-like a-amylase” is an a-amylase which has the amino acid sequence shown in SEQ ID NO: 2 herein or any ⁇ -amylase which displays at least 60%,
  • 25 such as at least 70%, e.g., at least 75%, or at least 80%, e . g. , at least 85%, at least 90% or at least 95% homology with SEQ ID NO; 2.
  • the "homology" may be determined by use of any conventional algorithm, preferably by use of the GAP progamme from the GCG
  • a structural alignment between Termamyl and a Termamyl-like ⁇ -amylase may be used to identify equivalent/corresponding positions in other Termamyl-like ⁇ -amylases.
  • One method of obtaining said structural alignment is to use the Pile Up programme from the GCG package using default values of gap penalties, i.e., a gap creation penalty of 3.0 and gap extension penalty of 0.1.
  • Other structural alignment methods include the hydrophobic cluster analysis (Gaboriaud et al . , (1987), FEBS LETTERS 224, pp. 149-155) and reverse threading (Huber, T ; Torda, AE, PROTEIN SCIENCE Vol. 7, No. 1 pp. 142-149 (1998).
  • the Termamyl-like ⁇ - amylase variant is one of the following B . licheniformis ⁇ - amylase variants (the parent B . li cheniformi s ⁇ -amylase is shown in SEQ ID NO: 2) :
  • the Termamyl-like ⁇ -amylase variant is one of the following substitutions B . licheniformis ⁇ -amylase variants with one of the following substitutions: V54W,Y or F or a Termamyl-like ⁇ -amylase variant with a substitution in a corresponding position.
  • Val54 variants may be constructed by standard techniques known in the art, including Site-directed mutagenesis a. described, e . g. , by Morinaga et al., (1984), Biotechnology 2, p.
  • Val54 variant may be expressed by cultivating a microorganism comprising a DNA sequence encoding the variant under conditions which are conducive for producing the variant. The variant may then subsequently be recovered from the resulting culture broth. Other methods known in the art may also be used. For instance WO 97/41213 discloses a suitable method for providing Val54 variants.
  • the invention also relates to a glucose syrup obtainable by the process of the invention as described above and illustrated below in the Examples section. Further, an aspect the invention also relates to the use of the glucose syrup obtainable by the process of the invention as ingredient in food products such as hard boiled candy, toffees, fudge, fondant and the like.
  • the invention relates to the use of a Termamyl-like ⁇ -amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone or a corresponding position in another Termamyl-like ⁇ -amylase for preparing a glucose syrup.
  • the Termamyl-like variant may be any of the above mentioned.
  • the variant may be prepared as described in WO 97/41213.
  • neocuproine assay Dist, Li Flor- idana(1965) Anal. Biochem. No 368.
  • the principle of the neocuproine assay is that CuS0 4 is added to the sample, Cu ++ is reduced by the reducing sugar and the formed neocuproine complex is measured at 450 nm.
  • a glucose syrup was prepared by treating a starch slurry containing 30% DS (30% Dry Solid) waxy maize starch, 40 ppm Ca 2+ (adding as CaCl 2 ) at pH 6.0 with 0.1 mg enzyme protein/g DS of Val54Trp substituted Bacillus licheniformis ⁇ -amylase. The temperature was kept at 95°C for one hour and 80°C for 72 hours .
  • the sugar profile of the prepared glucose syrup after 20 and 72 hours of treatment is shown in the Table 1 below:
  • Table 1 Sugar profile after 20 and 72 hours of treatment with V54W substituted Bacillus licheniformis ⁇ -amylase. The DE of the obtained syrup is also given.
  • Figure 3 shows the sugar spectrum of the glucose syrup obtained by treating a pre-cooked 5% Waxy maize starch substrate with a Val54Trp substituted Bacillus licheniformis ⁇ -amylase at 60°C for 24 hours.
  • Figure 2 shows the sugar spectrum of a 12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

The present invention relates to a process for the preparation of a glucose syrup wherein starch is treated with a Termamyl-like α-amylase comprising a substitution in Val54 shown in SEQ ID NO: 2 or in the corresponding position in another Termamyl-like α-amylase. The invention also relates to a glucose syrup obtainable by the process of the invention and the use thereof as ingredient in food products. An object of the invention is also to provide for the use of a Termamyl-like α-amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone or a corresponding position in another Termamyl-like α-amylase for preparing glucose syrup.

Description

ENZYMATIC PREPARATION OF GLUCOSE SYRUP FROM STARCH
FIELD OF THE INVENTION
The present invention relates to a process for the preparation of starch-hydrolysate syrups having characteristics which render them particularly attractive for a variety of industrial applications, notably in the food industry. The invention makes it possible using one enzyme, for the first time, to obtain syrups of the above-mentioned kind which closely match syrups whose preparation previously only feasible using acid hydrolysis ( i . e . , non-enzymatic hydrolysis) of starch.
BACKGROUND OF THE INVENTION
Glucose syrups with a DE (Dextrose Equivalent) around 42 is widely used in industry as an ingredient in products such as hard boiled candy, toffees, fudge, fondant and the like.
Traditionally 42 DE glucose syrups are produced by standard acid conversion. A starch slurry is initially acidified to pH 2, and is then pumped into a continuous reactor which operates at elevated temperature and pressure. After a period of time the liquor is returned to atmospheric conditions, neutralised, clarified, decolourised and concentrated to the final syrup. Such acid converted glucose syrup profile shown in Figure 1 reduce the tendency of sucrose to crystallise, they slow down the tendency to shell -graining and they contribute to the characteristic "mouth-feel" .
Today also enzymatic conversion of starch into glucose syrup has been suggested. However, such glucose syrups typically have a sugar spectrum which is quite different from the traditionally used 42 DE acid converted glucose syrup. SUMMARY OF THE INVENTION
The present invention is based on the finding that a glucose syrup with a DE in the range from 35 to 45 having a sugar spectrum close to that of the traditionally acid converted 42 DE glucose syrup can be obtained by treating starch with a 54 substituted variant of Termamyl® (which is a commercially available Bacillus lichenifor is α-amylase) .
In the first aspect the invention relates to a process for the preparation of a glucose syrup wherein starch is treated with a Termamyl-like α-amylase comprising a substitution in
Val54 shown in SEQ ID NO: 2 or in the corresponding position in another Termamyl-like α-amylase.
The invention also relates to a glucose syrup obtainable by the process of the invention. Further, an aspect the invention also relates to the use of said glucose syrup obtainable by the process of the invention as ingredient in food products such as hard boiled candy, toffees, fudge, fondant and the like.
Another object of the invention is to provide for the use of a Termamyl-like α-amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone (i.e., parent enzyme) or a corresponding position in another Termamyl-like α-amylase for preparing glucose syrup.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 shown the sugar spectrum of a 42 DE acid converted glucose syrup .
Figure 2 shows the sugar spectrum of a Termamyl® { i . e . , Bacillus licheniformis α-amylase from Novo Nordisk shown in SEQ ID NO: 2) converted glucose syrup. Figure 3 shows the sugar spectrum of a V54 substituted Bacillus licheniformis α-amylase variant converted glucose syrup of the invention.
Figure 4 is an alignment of the amino acid sequences of six parent Termamyl-like α-amylases. The numbers on the Extreme left designate the respective amino acid sequences as follows: 1: Bacillus sp . α-amylase, 2: Kaoamyl α-amylase), 3: Bacillus sp . α-amylase,
4: B . amyloliquefaciens α-amylase (BAN) (SEQ ID NO: 3), 5: Bacillus licheniformis α-amylase (SEQ ID NO: 2), 6: α-amylase disclosed in Tsukamoto et al . , Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31.
DETAILED DESCRIPTION OF THE INVENTION
The present invention is based on the finding that a novel glucose syrup with a DE in the range from 35 to 45 having a sugar spectrum and properties close to that of the traditionally acid converted glucose syrup, often referred to as "42 DE glucose syrup" is obtained by treating starch with a Val54Trp (V54 ) substituted variants of the commercially available Bacillus licheniformis α-amylase, sold under the trade name Termamyl® (Novo Nordisk) . The DNA and protein sequence of Termamyl® is displayed in SEQ ID NO: 1 and 2, respectively.
Substitution in the Val54 position of Termamyl-like α- amylases, including the B . licheniformis α-amylase, is known from WO 97/41213 (Novo Nordisk) . However, it is surprising that a Val54 substituted variant can be used to preparing a syrup~- from starch having a sugar spectrum which is close to that of an acid converted 42 DE glucose syrup as a glucose syrup prepared from starch treated with parent B . li cheniformis α- amylase (SEQ ID NO: 2) has a sugar spectrum quite different therefrom.
In the first aspect the invention relates to a glucose syrup (or speciality syrup) prepared by treating starch with the Bacillus licheniformis α-amylase shown in SEQ ID NO: 2 comprising a substitution in position Val54 or a Termamyl-like α-amylase (as defined below) substituted in a position corresponding to Val54 of SEQ ID NO: 2.
The glucose syrup of the invention has properties close to that of the traditional acid converted 42 DE syrups with regard to its sugar spectrum, i . e . , composition of dextrose (DPI), maltose (DP2) , maltotriose (DP3) , maltotetraose (DP4) , maltopentaose (DP5) and a number of higher sugars such as DP10 etc. The rheological properties, such as the viscosity, resembles the traditional acid converted DE 42 syrup much closer than a corresponding syrup prepared under the same conditions by treatment with parent B . licheniformis α-amylase { i . e . , SEQ ID NO: 2) .
As can been seen clearly by comparing Figure 1 to 3 a glucose syrup prepared by treating starch with the Val54Trp substituted Termamyl variant (Figure 3) has a sugar spectrum closer to that of the acid converted 42 DE syrup (Figure 1) than that of the glucose syrup prepared using parent B . licheniformis α-amylase (Figure 2) .
By using the Val54 substituted Bacillus licheniformis α- amylase variant for preparing a glucose syrup of the invention it can be seen that especially the DPI and DP4 sugar content has been increased to a level closer to that of the traditional 42 DE acid converted glucose syrup and the DP5 sugar content has been decreased to a level closer to that of the 42 DE glucose syrup in comparison to the corresponding glucose syrup prepared using parent B. licheniformis α-amylase. Further, the content of the higher sugars, as can be seen by comparing the peak(s) on the left side of Figures 1 to 3 , are also increased to a level closer to that of the acid converted 42 DE glucose syrup in comparison to corresponding parent B . licheniformis α-amylase converted starch glucose syrup.
According to the invention only one enzyme need to be used for producing the glucose syrup of the invention, i.e. Val54 substituted Termamyl-like α-amylase. The glucose syrup of the invention may be prepared by treating starch with a Val54 substituted Termamyl-like α- amylase variant for between 20 and 100 hours, preferably 50-80 hours, especially 60-75 hours at temperature in the range around 80-105°C. The pH should be in the range from pH 4-7, preferably from pH 4.5-6.5, especially around pH 5.5-6.2. To provide suitable conditions for Termamyl-like α-amylases, which generally seen have a high degree of Calcium dependency, from 20-60 ppm Ca2+, preferably around 40 ppm Ca2+ should be present in the reaction slurry. Enzymatic conversion of starch into a glucose syrup of the acid converted 42 DE syrup type should have a number of advantages including:
■ enzymatic conversion is a mild process,
■ reduction of the formation of colour precursor hydroxymethyl furfural ,
■ no formation of anhydroglucose as a by-product,
■ lower ash content because of a reduction in the acid requirements,
■ cheaper downstream processing and refining.
The Termamyl-like a-amylase According to the invention the Termamyl-like variant may be any α-amylases produced by Bacillus spp. with a high degree of homology on the amino acid level to SEQ ID NO. 2 herein, as will be defined below. A not exhaustive list of such enzymes are the following Bacillus sp. α-amylases :
B . amyloliquefaciens a-amylase disclosed in SEQ ID NO: 4 of WO 97/41213 which is about 89% homologous with the B . licheniformis α-amylase shown in SEQ ID NO: 2 below; the B . stearother ophilus a-amylase disclosed in SEQ ID NO: 6 in WO 97/41213. Further, homologous a-amylases include an a-amylase derived from a strain of the Bacillus sp . NCIB 12289, NCIB 12512, NCIB 12513 or DSM 9375, all of which are described in detail in WO 95/26397, and the a-amylase described by Tsukamoto et al . , Biochemical and Biophysical Research Communications, 151 (1988), pp. 25-31.
Other Bacillus s . α-amylases contemplated according to the present invention to be within the definition of Termamyl-like α-amylases are the α-amylases disclosed in SEQ ID NO. 1, 2, 3 and 7 of WO 96/23873 and variants thereof, including specifically the ones described in WO 96/23873.
Variants and hybrids of the above mentioned Termamyl-like α- amylases are also contemplated.
In an embodiment of the invention the parent Termamyl-like α-amylase is a hybrid α-amylase of SEQ ID NO: 2 and SEQ ID NO: 4. Specifically, the parent hybrid Termamyl-like α-amylase may be identical to the Termamyl sequence, i.e., the Bacillus licheni formis α-amylase shown in SEQ ID NO : 2, except that the N- terminal 35 amino acid residues (of the mature protein) has_ been replaced by the N-terminal 33 residues of BAN (mature protein) , i.e., the Bacillus amyloliquefaciens alpha-amylase shown in SEQ ID NO: 4 (the DNA sequence of the Bacillus amyloliquefa ciens alpha-amylase is displayed in SEQ ID NO: 3), which further may have the following mutations: H156Y+A181T+N190F+A209V+Q264S (using the numbering in SEQ ID NO: 5 2) . The hybrid may be constructed by SOE-PCR (Higuchi et al . 1988, Nucleic Acids Research 16:7351).
Still further Termamyl-like α-amylases include the α- amylase produced by the B . licheniformis strain described in EP 0,252,666 (ATCC 27811), and the α-amylases identified in WO
10 91/00353 and WO 94/18314. Other commercial Termamyl-like α-amylases are Optitherm™ and Takatherm™ (available from Sol- vay) , Maxamyl™ (available from Gist-Brocades/Genencor) , Spezyme AA™ and Spezyme Delta AA™ (available from Genencor) , and Keis- tase™ (available from Daiwa) .
15 Because of the substantial homology found between these a- amylases, they are considered to belong to the same class of a- amylases, namely the class of "Termamyl-like a-amylases".
Accordingly, in the present context, the term "Termamyl-like a-amylase" is also intended to indicate an a-amylase which, at
20 the amino acid level, exhibits a substantial homology to the B . licheniformis a-amylase having the amino acid sequence shown in SEQ ID NO: 2 herein. In other words, a "Termamyl-like a-amylase" is an a-amylase which has the amino acid sequence shown in SEQ ID NO: 2 herein or any α-amylase which displays at least 60%,
25 such as at least 70%, e.g., at least 75%, or at least 80%, e . g. , at least 85%, at least 90% or at least 95% homology with SEQ ID NO; 2.
The "homology" may be determined by use of any conventional algorithm, preferably by use of the GAP progamme from the GCG
30 package version 7.3 (June 1993) using default values for GAP penalties, which is a GAP creation penalty of 3.0 and GAP extension penalty of 0.1, (Genetic Computer Group (1991) Programme Manual for the GCG Package, version 7, 575 Science Drive, Madison, Wisconsin, USA 53711) .
A structural alignment between Termamyl and a Termamyl-like α-amylase may be used to identify equivalent/corresponding positions in other Termamyl-like α-amylases. One method of obtaining said structural alignment is to use the Pile Up programme from the GCG package using default values of gap penalties, i.e., a gap creation penalty of 3.0 and gap extension penalty of 0.1. Other structural alignment methods include the hydrophobic cluster analysis (Gaboriaud et al . , (1987), FEBS LETTERS 224, pp. 149-155) and reverse threading (Huber, T ; Torda, AE, PROTEIN SCIENCE Vol. 7, No. 1 pp. 142-149 (1998).
In an embodiment of the invention the Termamyl-like α- amylase variant is one of the following B . licheniformis α- amylase variants (the parent B . li cheniformi s α-amylase is shown in SEQ ID NO: 2) :
V54A,R,D,N,C,E,Q,G,H,I,L,K,M,F,P,S,T,W,Y or a Termamyl-like α- amylase or variant (as defined above) with a substitution in a position corresponding to Val54 in SEQ ID NO: 2.
In a preferred embodiment the Termamyl-like α-amylase variant is one of the following substitutions B . licheniformis α-amylase variants with one of the following substitutions: V54W,Y or F or a Termamyl-like α-amylase variant with a substitution in a corresponding position.
Construction of variants of the invention
The Val54 variants may be constructed by standard techniques known in the art, including Site-directed mutagenesis a. described, e . g. , by Morinaga et al., (1984), Biotechnology 2, p.
646-639, and in US patent no. 4,760,025. Another suitable method introducing mutations into α-amylase-encoding DNA sequences is described in Nelson and Long, (1989) , Analytical Biochemistry 180, p. 147-151. This method involves a 3-step generation of a PCR fragment containing the desired mutation introduced by using a chemical synthesized DNA strand as one primer in the PCR reaction. From the PCR-generated fragment, a DNA fragment carrying the mutation may be isolated by cleavage with restriction endonuclease and reinserted into an expression plasmid. A Val54 variant may be expressed by cultivating a microorganism comprising a DNA sequence encoding the variant under conditions which are conducive for producing the variant. The variant may then subsequently be recovered from the resulting culture broth. Other methods known in the art may also be used. For instance WO 97/41213 discloses a suitable method for providing Val54 variants.
The invention also relates to a glucose syrup obtainable by the process of the invention as described above and illustrated below in the Examples section. Further, an aspect the invention also relates to the use of the glucose syrup obtainable by the process of the invention as ingredient in food products such as hard boiled candy, toffees, fudge, fondant and the like.
In another aspect the invention relates to the use of a Termamyl-like α-amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone or a corresponding position in another Termamyl-like α-amylase for preparing a glucose syrup. The Termamyl-like variant may be any of the above mentioned.
MATERIALS AND METHODS Materials 10
Enzyme :
Termamyl® from Novo Nordisk shown in SEQ ID NO: 2 substituted in position Val54Trp. The variant may be prepared as described in WO 97/41213.
Other materials:
Waxy maize starch from Cerestar.
Methods
DE determination
DE (dextrose equivalent is defined as the amount of reducing carbohydrate ( measured as dextrose-equivalents) in a sample expressed as w/w% of the total amount of dissolved dry mat- ter) . It is measured by the neocuproine assay (Dygert, Li Flor- idana(1965) Anal. Biochem. No 368). The principle of the neocuproine assay is that CuS04 is added to the sample, Cu++ is reduced by the reducing sugar and the formed neocuproine complex is measured at 450 nm.
General molecular biology methods:
DNA manipulations and transformations were performed using standard methods of molecular biology (Sambrook et al . (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, NY; Ausubel, F. M. et al . (eds.) "Current protocols in Molecular Biology". John Wiley and Sons, 1995; Harwood, C. R. , and Cutting, S. M. (eds.) "Molecular Biological Methods for Bacillus". John Wiley and Sons, 1990).
Enzymes for DNA manipulations were used according to the specifications of the suppliers.
EXAMPLES 11
Example 1
Preparation of glucose syrup of the acid converted-type enzy- maticallv
A glucose syrup was prepared by treating a starch slurry containing 30% DS (30% Dry Solid) waxy maize starch, 40 ppm Ca2+ (adding as CaCl2) at pH 6.0 with 0.1 mg enzyme protein/g DS of Val54Trp substituted Bacillus licheniformis α-amylase. The temperature was kept at 95°C for one hour and 80°C for 72 hours . The sugar profile of the prepared glucose syrup after 20 and 72 hours of treatment is shown in the Table 1 below:
%DPx on DS Time (Hours)
20 72
DPI 7.9 10.1
DP2 19.1 23.2
DP3 14.3 14.0
DP4 8.6 7.6
DP5 8.5 6.6
DP6 2.4 2.4
DP7 3.1 4.1
DP8 3.1 3.4
DP9 2.5 2.4
DP10+ 30.5 26.4
DE 35 43
Table 1: Sugar profile after 20 and 72 hours of treatment with V54W substituted Bacillus licheniformis α-amylase. The DE of the obtained syrup is also given. Figure 3 shows the sugar spectrum of the glucose syrup obtained by treating a pre-cooked 5% Waxy maize starch substrate with a Val54Trp substituted Bacillus licheniformis α-amylase at 60°C for 24 hours. Figure 2 shows the sugar spectrum of a 12
similar substrate treated with the native Bacillus licheni formis α-amylase under similar conditions

Claims

13CLAIMS
1. A process for the preparation of a glucose syrup wherein starch is treated with a Termamyl-like ╬▒-amylase comprising a substitution in Val54 shown in SEQ ID NO: 2 or in the corresponding position in another Termamyl-like ╬▒-amylase.
2. The process according to claim 1, wherein the variant is one of the following variants: V54A,R,D,N,C,E,Q,G,H, I , L, K, M, F, P, S , T, W, Y using the B . licheniformis ╬▒-amylase as the backbone or another Termamyl- like variant with a corresponding substitution.
3. The process according to claim 2, wherein the Termamyl-like variant as one of the following substitutions: V54W, Y or F or a corresponding variant in another Termamyl-like ╬▒-amylase.
4. The process according to claims 1-3, wherein the starch is treated with an ╬▒-amylase variant of any of claims 2 to 4 for from 20 to 100 hours, preferably 50-80 hours, especially 60-75 hours .
5. A glucose syrup obtainable by the process according to any of claims 1 to 4.
6. Use of a glucose syrup according to claim 5 as ingredient in food products .
7. Use of a Termamyl-like ╬▒-amylase with a substitution in position Val54 using SEQ ID NO: 2 as the backbone or a 14
corresponding position in another Termamyl-like ╬▒-amylase for preparing glucose syrup.
8. The use according to claim 7, wherein the B . licheniformis ╬▒-amylase shown in SEQ ID NO: 2 is the backbone if the variant .
9. The use according to claim 8, wherein the variant is one of the following: V54A, R, D,N, C, E, Q, G,H, I , L, K, M, F, P, S , T, W, Y using the B . licheniformis ╬▒-amylase as the backbone or another Termamyl-like variant with a corresponding substitution.
EP99906094A 1998-03-09 1999-03-08 Enzymatic preparation of glucose syrup from starch Withdrawn EP1062359A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK32198 1998-03-09
DK32198 1998-03-09
PCT/DK1999/000114 WO1999046399A1 (en) 1998-03-09 1999-03-08 Enzymatic preparation of glucose syrup from starch

Publications (1)

Publication Number Publication Date
EP1062359A1 true EP1062359A1 (en) 2000-12-27

Family

ID=8092240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99906094A Withdrawn EP1062359A1 (en) 1998-03-09 1999-03-08 Enzymatic preparation of glucose syrup from starch

Country Status (7)

Country Link
EP (1) EP1062359A1 (en)
JP (1) JP2002505885A (en)
KR (1) KR20010041617A (en)
AR (1) AR020058A1 (en)
AU (1) AU2612499A (en)
CA (1) CA2323068A1 (en)
WO (1) WO1999046399A1 (en)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174511A4 (en) * 1999-03-08 2004-03-31 Showa Sangyo Co PROMOTERS
CN105492603B (en) 2013-05-29 2022-06-03 丹尼斯科美国公司 Novel metalloproteases
WO2014194054A1 (en) 2013-05-29 2014-12-04 Danisco Us Inc. Novel metalloproteases
JP6367930B2 (en) 2013-05-29 2018-08-01 ダニスコ・ユーエス・インク Novel metalloprotease
EP3004314B1 (en) 2013-05-29 2018-06-20 Danisco US Inc. Novel metalloproteases
DK3080263T3 (en) 2013-12-13 2019-10-07 Danisco Us Inc SERIN PROTEASES OF BACILLUS GIBSONII-CLADE
TR201906371T4 (en) 2013-12-13 2019-05-21 Danisco Inc Serine proteases of Bacillus species.
KR20160099629A (en) 2013-12-16 2016-08-22 이 아이 듀폰 디 네모아 앤드 캄파니 Use of poly alpha-1,3-glucan ethers as viscosity modifiers
MX381013B (en) 2013-12-18 2025-03-12 Nutrition & Biosciences Usa 4 Inc CATIONIC POLY-ALPHA-1,3-GLUCAN ETHERS.
WO2015123323A1 (en) 2014-02-14 2015-08-20 E. I. Du Pont De Nemours And Company Poly-alpha-1,3-1,6-glucans for viscosity modification
US9695253B2 (en) 2014-03-11 2017-07-04 E I Du Pont De Nemours And Company Oxidized poly alpha-1,3-glucan
DK3119884T3 (en) 2014-03-21 2019-10-14 Danisco Us Inc SERIN PROTEAS OF BACILLUS SPECIES
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015195777A1 (en) 2014-06-19 2015-12-23 E. I. Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US20170233710A1 (en) 2014-10-17 2017-08-17 Danisco Us Inc. Serine proteases of bacillus species
WO2016069557A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases of bacillus species
EP3957729A1 (en) 2014-10-27 2022-02-23 Danisco US Inc. Serine proteases
WO2016069548A2 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
WO2016069544A1 (en) 2014-10-27 2016-05-06 Danisco Us Inc. Serine proteases
EP3212662B1 (en) 2014-10-27 2020-04-08 Danisco US Inc. Serine proteases
US10131929B2 (en) 2014-12-23 2018-11-20 E. I. Du Pont De Nemours And Company Enzymatically produced cellulose
US20180112204A1 (en) 2015-05-13 2018-04-26 Danisco Us Inc. AprL-CLADE PROTEASE VARIANTS AND USES THEREOF
WO2016201040A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc. Water-triggered enzyme suspension
WO2016201069A1 (en) 2015-06-09 2016-12-15 Danisco Us Inc Low-density enzyme-containing particles
US20180134997A1 (en) 2015-06-09 2018-05-17 Danisco Us Inc. Osmotic burst encapsulates
EP3310911B1 (en) 2015-06-17 2023-03-15 Danisco US Inc. Bacillus gibsonii-clade serine proteases
JP7364330B2 (en) 2015-11-05 2023-10-18 ダニスコ・ユーエス・インク Mannanase of Paenibacillus sp. and Bacillus sp.
JP7364331B2 (en) 2015-11-05 2023-10-18 ダニスコ・ユーエス・インク Paenibacillus sp. mannanase
JP2019504932A (en) 2015-11-13 2019-02-21 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ Glucan fiber composition for use in laundry and textile care
EP3374400B1 (en) 2015-11-13 2022-04-13 Nutrition & Biosciences USA 4, Inc. Glucan fiber compositions for use in laundry care and fabric care
WO2017083226A1 (en) 2015-11-13 2017-05-18 E. I. Du Pont De Nemours And Company Glucan fiber compositions for use in laundry care and fabric care
WO2017100720A1 (en) 2015-12-09 2017-06-15 Danisco Us Inc. Alpha-amylase combinatorial variants
US20180362946A1 (en) 2015-12-18 2018-12-20 Danisco Us Inc. Polypeptides with endoglucanase activity and uses thereof
CN109715791B (en) 2016-05-03 2023-07-14 丹尼斯科美国公司 Protease variants and uses thereof
BR112018072586A2 (en) 2016-05-05 2019-02-19 Danisco Us Inc protease variants and uses thereof
US11661567B2 (en) 2016-05-31 2023-05-30 Danisco Us Inc. Protease variants and uses thereof
MX2018015559A (en) 2016-06-17 2019-06-06 Danisco Us Inc Protease variants and uses thereof.
EP3535365A2 (en) 2016-11-07 2019-09-11 Danisco US Inc. Laundry detergent composition
CN110312794B (en) 2016-12-21 2024-04-12 丹尼斯科美国公司 Bacillus gibsonii clade serine protease
CN110312795B (en) 2016-12-21 2024-07-23 丹尼斯科美国公司 Protease variants and uses thereof
US11453871B2 (en) 2017-03-15 2022-09-27 Danisco Us Inc. Trypsin-like serine proteases and uses thereof
EP3601553B1 (en) 2017-03-31 2025-12-03 Danisco US Inc. Alpha-amylase combinatorial variants
EP3601515A1 (en) 2017-03-31 2020-02-05 Danisco US Inc. Delayed release enzyme formulations for bleach-containing detergents
CA3067837A1 (en) 2017-06-30 2019-01-03 Danisco Us Inc Low-agglomeration, enzyme-containing particles
EP3668973A2 (en) 2017-08-18 2020-06-24 Danisco US Inc. Alpha-amylase variants
CN111373039A (en) 2017-11-29 2020-07-03 丹尼斯科美国公司 Subtilisin variants having improved stability
CN111742041B (en) 2017-12-21 2023-06-06 丹尼斯科美国公司 Enzyme-containing hot-melt granules containing a heat-resistant desiccant
BR112020016068A2 (en) 2018-02-08 2020-12-08 Danisco Us Inc. THERMALLY RESISTANT MATRIX WAX PARTICLES FOR ENZYME ENCAPSULATION
US12415996B2 (en) 2018-06-19 2025-09-16 Danisco Us Inc. Subtilisin variants
US20210363470A1 (en) 2018-06-19 2021-11-25 Danisco Us Inc Subtilisin variants
US20230174962A1 (en) 2018-07-31 2023-06-08 Danisco Us Inc Variant alpha-amylases having amino acid substitutions that lower the pka of the general acid
EP3844255A1 (en) 2018-08-30 2021-07-07 Danisco US Inc. Enzyme-containing granules
EP3856882A1 (en) 2018-09-27 2021-08-04 Danisco US Inc. Compositions for medical instrument cleaning
WO2020077331A2 (en) 2018-10-12 2020-04-16 Danisco Us Inc Alpha-amylases with mutations that improve stability in the presence of chelants
EP3887515A1 (en) 2018-11-28 2021-10-06 Danisco US Inc. Subtilisin variants having improved stability
CN114174504A (en) 2019-05-24 2022-03-11 丹尼斯科美国公司 Subtilisin variants and methods of use
CN114174486A (en) 2019-06-06 2022-03-11 丹尼斯科美国公司 Methods and compositions for cleaning
BR112022007697A2 (en) 2019-10-24 2022-07-12 Danisco Us Inc VARIANT ALPHA-AMYLASE THAT FORMS MALTOPENTAOSE/MALTOHEXAOSE
WO2022047149A1 (en) 2020-08-27 2022-03-03 Danisco Us Inc Enzymes and enzyme compositions for cleaning
WO2022165107A1 (en) 2021-01-29 2022-08-04 Danisco Us Inc Compositions for cleaning and methods related thereto
WO2022199418A1 (en) 2021-03-26 2022-09-29 Novozymes A/S Detergent composition with reduced polymer content
WO2023278297A1 (en) 2021-06-30 2023-01-05 Danisco Us Inc Variant lipases and uses thereof
EP4396320A2 (en) 2021-09-03 2024-07-10 Danisco US Inc. Laundry compositions for cleaning
CN117957318A (en) 2021-09-13 2024-04-30 丹尼斯科美国公司 Particles containing biologically active substances
EP4448750A2 (en) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisin variants and uses thereof
WO2023114988A2 (en) 2021-12-16 2023-06-22 Danisco Us Inc. Variant maltopentaose/maltohexaose-forming alpha-amylases
EP4448749A2 (en) 2021-12-16 2024-10-23 Danisco US Inc. Subtilisin variants and methods of use
CN118679251A (en) 2021-12-16 2024-09-20 丹尼斯科美国公司 Subtilisin variants and methods of use
WO2023168234A1 (en) 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CN119487167A (en) 2022-06-21 2025-02-18 丹尼斯科美国公司 Compositions and methods for cleaning comprising polypeptides having thermolysin activity
CA3265943A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Detergent compositions and methods related thereto
WO2024050339A1 (en) 2022-09-02 2024-03-07 Danisco Us Inc. Mannanase variants and methods of use
CN120112635A (en) 2022-09-02 2025-06-06 丹尼斯科美国公司 Subtilisin variants and methods related thereto
WO2024102698A1 (en) 2022-11-09 2024-05-16 Danisco Us Inc. Subtilisin variants and methods of use
EP4658776A1 (en) 2023-02-01 2025-12-10 Danisco US Inc. Subtilisin variants and methods of use
WO2024186819A1 (en) 2023-03-06 2024-09-12 Danisco Us Inc. Subtilisin variants and methods of use
EP4680013A1 (en) 2023-03-16 2026-01-21 Nutrition & Biosciences USA 4, Inc. Brevibacillus fermentate extracts for cleaning and malodor control and use thereof
WO2025071996A1 (en) 2023-09-28 2025-04-03 Danisco Us Inc. Variant cutinase enzymes with improved solubility and uses thereof
WO2025085351A1 (en) 2023-10-20 2025-04-24 Danisco Us Inc. Subtilisin variants and methods of use
WO2026024922A1 (en) 2024-07-25 2026-01-29 Danisco Us Inc. Subtilisin variants and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK311186D0 (en) * 1986-06-30 1986-06-30 Novo Industri As ENZYMES
KR960006119B1 (en) * 1986-07-09 1996-05-09 노보 노르디스크 아크티에 셀스카브 Starch liquefaction with alpha amylase mixtures
CN1246455C (en) * 1996-04-30 2006-03-22 诺沃奇梅兹有限公司 Alpha amylase mutants
ATE210730T1 (en) * 1996-09-17 2001-12-15 Amylum Europe Nv GLUCOSE SYRUP WITH SPECIAL PROPERTIES AND PROCESS FOR ITS PRODUCTION

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9946399A1 *

Also Published As

Publication number Publication date
KR20010041617A (en) 2001-05-25
JP2002505885A (en) 2002-02-26
AU2612499A (en) 1999-09-27
CA2323068A1 (en) 1999-09-16
WO1999046399A1 (en) 1999-09-16
AR020058A1 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
WO1999046399A1 (en) Enzymatic preparation of glucose syrup from starch
Crabb et al. Commodity scale production of sugars from starches
Brown et al. Characterization of amylolytic enzymes, having both α-1, 4 and α-1, 6 hydrolytic activity, from the thermophilic archaea Pyrococcus furiosus and Thermococcus litoralis
CN100436591C (en) Method for producing and preparing dextran
CN101939421B (en) Variants of bacillus stearothermophilus alpha-amylase and uses thereof
WO1999027124A1 (en) Enzymatic starch saccharification including a membrane separation step
US6287826B1 (en) Enzymatic preparation of glucose syrup from starch
Kim et al. Characterization of novel thermophilic alpha-glucosidase from Bifidobacterium longum
Comfort et al. Strategic biocatalysis with hyperthermophilic enzymes
US4970158A (en) Beta amylase enzyme product, preparation and use thereof
Yamamoto Enzyme chemistry and molecular biology of amylases and related enzymes
EP0405283A2 (en) Novel thermoduric and aciduric pullulanase enzyme and method for its production
WO2005056811A1 (en) METHOD OF CONVERTING β-1,4-GLUCAN TO α-GLUCAN
JP4656620B2 (en) Preparation of sucrose phosphorylase
JPS63102678A (en) Amylase and its production, and formation of maltose and maltotriose from starch or starch hydrolysate using the same
WO2002010427A1 (en) Method for producing maltose syrup by using a hexosyltransferase
Dobreva et al. Effect of temperature on some characteristics of the thermostable α-amylase from Bacillus licheniformis
JP5319270B2 (en) Method for converting glucose to α-1,4-glucan
JPH10506524A (en) A novel acid-tolerant enzyme from Sulfolobus species
Butler et al. Starch-acting enzymes
KR100387286B1 (en) Method for production of isomaltooligosaccharides
DK149157B (en) PROCEDURE FOR PREPARING A HEAT AND ACID STABLE ALFA AMYLASE ENZYM
US9222114B1 (en) Thermophilic phosphatases and methods for processing starch using the same
Sharmila et al. Fermentative extraction of Amylase using waste Biomaterials as Substrate
Suzuki Recent advances of starch science and starch technology in Japan

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001009

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVOZYMES A/S

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020930